Bioconvergence and non-human primate models in human metapneumovirus research

Abstract

Human metapneumovirus (HMPV) poses a significant global health threat. While nonhuman primates (NHPs) remain crucial models, ethical and economic limitations necessitate complementary approaches. Advanced bioconvergence technologies, including organoids, artificial intelligence (AI), and quantum computing, offer scalable, cost-effective, and ethical solutions, enhancing HMPV research, antiviral development, and future clinical applications.